Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyprofol Dosing in Infants Undergoing Cochlear Implantation
ChiCTR2300067354Phase 4Not yet recruiting
- Sponsor
- Bethune International Peace Hospital
- Start
- Jan 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol (3 arms), sponsored by Bethune International Peace Hospital. Primary endpoint: 90% Effective Dose of Cyprofol. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300067354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067354.